Introducing “NovoHeal” for HPV Recurrence Prevention

At the 21st International Congress of the Iranian Society of Obstetricians and Gynecologists, Faran Shimi Pharmaceutical Company, a member of Golrang Pharmaceutical Group, unveiled two new products: NovoHeal and Duralife. With over two decades of experience in Iran’s pharmaceutical industry, Faran Shimi continues to pioneer in the development of innovative and effective therapeutic solutions.

According to Golrang Pharmaceutical Group’s Public Relations, Erfan Iranmanesh, Marketing Manager at Faran Shimi, highlighted that NovoHeal is a natural formulation designed to help prevent the recurrence of lesions caused by the Human Papillomavirus (HPV). The main active ingredients are propolis (bee resin) and echinacea, both of which have been scientifically studied for their immune-boosting properties and their potential role in reducing the risk of HPV lesion recurrence.

“Many patients with HPV face a recurrence of lesions within a year of initial treatment due to immune system vulnerability,” Iranmanesh explained. “NovoHeal serves as a supportive, non-prescription supplement to help reduce this risk.”

Affordable, Accessible, and Backed by Science

NovoHeal is available over-the-counter (OTC) in pharmacies across Iran and is offered at a competitive price compared to foreign alternatives, making it more accessible to a wider patient base. The product has already gained interest and approval from gynecology specialists.

Complementary Product: Duralife for PMS Support

Alongside NovoHeal, Duralife was also introduced. This natural supplement contains saffron, magnesium, and vitamin B6, and is formulated to alleviate symptoms of premenstrual syndrome (PMS) and improve mood balance. Like NovoHeal, Duralife is also available OTC and has been positively received by its target market.

Faran Shimi’s focus on evidence-based, plant-derived formulations reflects a growing commitment to women’s health and innovation in therapeutic supplements. The company continues to prioritize research-driven development and aims to expand its footprint in both domestic and international markets.

Latest Articles